ERT Awarded over $10 Million of ePRO Business from Major Pharma

May 12, 2011

Company News Release

ERT announced that it was awarded three new contracts with top tier pharmaceutical companies, totaling over $10 million for its electronic patient reported outcomes (ePRO) business. The company has been selected to provide its diverse multi-modality solutions.

ERT is gaining increasing market share in the ePRO market. ERT offers a broad range of ePRO solutions to collect accurate subject self-reports and real-time data during a clinical trial. The most significant ePRO award is an exclusive agreement with a specialty division of a top 5 pharmaceutical company that has selected ERT to manage a suite of studies using ERT’s proprietary VIAPhone platform over the next three years. The contract will be worth in excess of $7.0 million. The second award is part of a $3.0 million contract for which ERT will provide its VIAPen solution for a pivotal Phase III program. The third award has been secured with a top 10 pharmaceutical company who will be using ERT’s unique VIAPhone Pain Diary for use in a Phase III clinical trial, alongside its VIAPen solution for site assessments, as part of a $1.2 million contract.

Related Content:

News